Figure 5 Mechanisms of adiponectin actions in the kidney

Slides:



Advertisements
Similar presentations
Figure 2 Inflammatory pathways affecting hepatic insulin resistance
Advertisements

Figure 2 Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis Figure 2 | Crosstalk between TGF-β/Smad and other pathways in tissue fibrosis.
Figure 6 Effects of adiponectin on podocyte function
Figure 3 Metabolism in homeostatic chondrocytes
Figure 3 Energy metabolism regulation, cardiovascular and bone disease in CKD Figure 3 | Energy metabolism regulation, cardiovascular and bone disease.
Figure 4 Expression of coagulation protease receptors in renal cells
Figure 3 Angiotensin signalling in adiporenal crosstalk
Figure 4 Interactions between adipose, the microbiome and kidney
Nat. Rev. Nephrol. doi: /nrneph
Figure 2 Proinflammatory mechanisms in CKD
Figure 1 Circadian changes in energy metabolism and immune responses in CKD Figure 1 | Circadian changes in energy metabolism and immune responses in CKD.
Figure 3 The fat–intestine–kidney axis
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Pathogenic mechanisms and pathways in ADPKD
Figure 3 Putative actions of glucagon-like peptide 1 (GLP-1)
Figure 1 mTOR pathway activation
Figure 2 The network of chronic diseases and their mutual influences
Figure 2 Three distinct mechanisms of activation of
Figure 1 The sensory and secretory function of the L cell
Figure 1 The burden of chronic kidney disease (CKD)
Nat. Rev. Nephrol. doi: /nrneph
Figure 2 Molecular pathways involved in the regulation of T-cell differentiation and cytokine production Figure 2 | Molecular pathways involved in the.
Figure 1 Acute kidney injury and chronic kidney disease
Figure 4 Altered metabolism in chondrocytes in osteoarthritis
Figure 2 Roles of mTOR complexes in the kidney
Figure 2 Molecular mechanisms of the antidiabetic
Pascal Ferré, Fabienne Foufelle  Cell Metabolism 
Figure 5 Consequences of CKD on lipid metabolism
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 mTOR complex biology
Review AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism CELL METABOLISM : JANUARY 2005 · VOL.
eCB pathways involved in obesity-/HFD-associated CKD
Figure 1 The coagulation system
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Specificity of the various epidermal growth factor (EGF)
Figure 2 Organ crosstalk in the pathophysiology
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Simplified representation of the physiological
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Distinct features of adipocytes
Figure 1 The insulin signalling pathway
Nat. Rev. Nephrol. doi: /nrneph
Figure 4 Mechanisms of leptin function on kidney injury
Exercise Pills: At the Starting Line
Daniel Garcia, Reuben J. Shaw  Molecular Cell 
Nat. Rev. Rheumatol. doi: /nrrheum
Figure 3 Regulation of TGF-β1/Smad signalling by microRNAs (miRs) in tissue fibrosis Figure 3 | Regulation of TGF-β1/Smad signalling by microRNAs (miRs)
Nat. Rev. Rheumatol. doi: /nrrheum
Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph
The genetics of alcohol dependence and alcohol-related liver disease
Figure 2 Lipid metabolism and metabolism-disrupting chemicals.
Figure 2 Mechanisms of crosstalk between adipocytes and the kidney
Estrogen Receptors and the Metabolic Network
Nat. Rev. Nephrol. doi: /nrneph
Konstantinos G. Michalakis, M.D., James H. Segars, M.D. 
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Nat. Rev. Nephrol. doi: /nrneph
Volume 70, Issue 10, Pages (November 2006)
A Ceramide-Centric View of Insulin Resistance
primary Sjögren syndrome
Toshimasa Yamauchi, Takashi Kadowaki  Cell Metabolism 
Metabolic Integration and Organ Specialization
Nat. Rev. Endocrinol. doi: /nrendo
Daniel Garcia, Reuben J. Shaw  Molecular Cell 
Figure 2 Protective functions of HDL
Fig. 1. Hypothesis: mitochondrial dysfunction in adipocytes may be a primary cause of adipose tissue inflammation. Hypertrophic adipocytes in obesity or.
Figure 1. The relationship between the core clock mechanism and metabolic factors. CLOCK and BMAL1 mediate the ... Figure 1. The relationship between the.
Volume 76, Issue 2, Pages (July 2009)
Presentation transcript:

Figure 5 Mechanisms of adiponectin actions in the kidney Figure 5 | Mechanisms of adiponectin actions in the kidney. Adipocytes are the major source of circulating adiponectin, although the kidneys might also produce it. Adiponectin acts upon its receptors, ADIPOR1 and ADIPOR2, to activate 5′-AMP-activated protein kinase catalytic subunit α-1 (PRKAA1; also known as AMPK) and peroxisome proliferator-activated receptor-α (PPARα) signalling, respectively. Adiponectin receptors also possess ceramidase activity, which enables ceramides to be converted to sphingosines and fatty acids. Combined, these actions of adiponectin coordinately regulate energy metabolism, cellular oxidative stress and inflammation. Dysregulation of these cellular events can lead to various renal abnormalities, including fibrosis, glomerulosclerosis and albuminuria. Some compounds such as 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), resveratrol (RSV) and berberine (BBR) elevate circulating adiponectin levels and thus improve kidney dysfunction by enhancing adiponectin signalling. In addition, direct activation of AMPK by compounds such as PF-06409577 and PF-249 also ameliorate kidney disease. CaMKK 2, calcium/calmodulin-dependent protein kinase kinase 2; LBK1 (also known as STK11), serine/threonine-protein kinase STK11. Zhu, Q. & Scherer, P. E. (2017) Immunologic and endocrine functions of adipose tissue: implications for kidney disease Nat. Rev. Nephrol. doi:10.1038/nrneph.2017.157